The catecholamine hypothesis of affective disorders: a review of supporting evidence
about
Circadian rhythm hypotheses of mixed features, antidepressant treatment resistance, and manic switching in bipolar disorderAn Evolutionary Framework to Understand Foraging, Wanting, and Desire: The Neuropsychology of the SEEKING SystemComparative effects of d-amphetamine, l-amphetamine and methylphenidate on mood in manBiochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemideA profile of nomifensine.Sigma receptors: potential targets for a new class of antidepressant drugIn a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis.Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitorsUnfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacyNeurotransmitter transporters and their impact on the development of psychopharmacologyThe effects of mianserine, amitriptyline, ciclazindol and viloxazine on presynaptic alpha-receptors in isolated rat atria [proceedings]The pharmacology of fluparoxan: a selective alpha 2-adrenoceptor antagonistEffects of iprindole on responses of single cortical and caudate neurones to monoamines and acetylcholineThe role of monoamine oxidase inhibitors in current psychiatric practiceThe noradrenergic paradox: implications in the management of depression and anxietyProfile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literatureApplications of magnetic resonance imaging for treatment-resistant late-life depressionThe 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouseMemantine: New prospective in bipolar disorder treatmentCognitive mechanisms of treatment in depressionTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateBipolar spectrum: a review of the concept and a vision for the futureSerotonin-kynurenine hypothesis of depression: historical overview and recent developmentsA brief history of the development of antidepressant drugs: from monoamines to glutamateThe effects of drugs on human models of emotional processing: an account of antidepressant drug treatmentThe Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's DiseaseCircuit to construct mapping: a mathematical tool for assisting the diagnosis and treatment in major depressive disorderTobacco addiction and the dysregulation of brain stress systems.Neurotransmitter transporters: fruitful targets for CNS drug discoveryAssociation of monoamine oxidase A (MAOA) polymorphisms and clinical subgroups of major depressive disorders in the Han Chinese populationInvited review: the evolution of antidepressant mechanismsDepression: a new animal model sensitive to antidepressant treatmentsCase history: the discovery of fluoxetine hydrochloride (Prozac)The other face of depression, reduced positive affect: the role of catecholamines in causation and cureFluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptakeForced swimming test in mice: a review of antidepressant activityThe noradrenergic action in antidepressant treatments: pharmacological and clinical aspectsRegulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.Platelet monoamine oxidase activity in megaloblastic anaemia.
P2860
Q22241088-8862E5B5-794D-4B8C-8070-7323A594ECCEQ22242984-2A37A4BD-4351-494F-A082-932F6C4BADF9Q22252823-E7BF582A-2641-4995-95D4-F317BCE9593BQ24535668-4C947649-FE9A-4650-A49F-AE5A9ADBC3CFQ24547844-971B09D0-0AF1-42C3-A924-4553C1AE6215Q24567770-85188C30-BBA7-472A-A90B-A516A7C3BC91Q24605563-2CAC53C0-65F0-4D51-845B-B6B86B14BB9DQ24632936-DD9C7E2B-C9BF-46CE-9065-4CB258268561Q24645072-3C2860DB-496D-4BC4-B1A7-0BED918D7509Q24658095-6D621473-04B9-4100-B913-2450B1A3FD40Q24670273-5BEDC369-A0C0-418B-AA73-989A772CB62CQ24672667-BB95BA60-4AF6-4D46-B3E3-5E79087BAE2EQ24673328-3DA98F15-763C-4975-B0AE-22A90605BC51Q24676416-FAB3A7F1-5469-40A9-AEE7-C9F606E76C35Q24679460-41953940-C6C3-4328-A1EE-2228336C5C19Q26752868-9BB2C340-C7F6-43A5-8D56-BD6FA20A528DQ26796436-E0FCF025-E5F9-488E-BA41-172C416DDACCQ26798235-265517DF-0F6B-4B0B-A9DA-60E7906CEC16Q26849351-887700D3-6D79-47C2-9A3A-5271CF817648Q26852133-DEB4D512-76A0-4514-BA5C-0803CEC4EC37Q27001088-69F307B9-103B-464A-9F1D-99F18424D87EQ27004490-3D676B16-E69F-42A5-B1E9-B3C6C3EB6D6CQ27010258-43B2FF25-2646-4D42-A626-8D4A15FB9E10Q27012779-92E3F639-D8E3-499C-B9C4-17EB22E37587Q27028050-92ADF0DD-3F65-4F90-A272-752A2CD50F21Q28072345-F426F08E-20C3-4ED0-8537-7641C44ADCA1Q28078546-8189CB70-8005-40F8-A3B8-A418F107B29EQ28085697-5160B753-2B3A-4DA9-8FEE-A466E58CCE9FQ28111988-8BA6F111-BF64-408C-B993-8AFEBF5349DBQ28140501-1903C07C-F23C-4FC7-85AB-B7550F0E1665Q28235468-888AC4BE-9279-404D-B19F-6372FC248F79Q28241221-C93AC8F5-151F-426E-8618-7058E4E8C2B5Q28254150-7BD69E91-660C-40FF-BA00-37B244215FCFQ28268856-96F9DB06-AE47-48DF-8B02-80340BA44B9AQ28269179-D70E26FC-83CD-4019-B9B0-B869AFDAC15DQ28293369-6521C639-84A4-45ED-8526-D9095BDE8C60Q28299108-5BA31803-37DF-4DAC-86F0-5639461D314BQ28300843-0DF5B0D3-4826-4C9F-B49D-204470D655ECQ28322232-0CFA5D0C-8A50-4655-9C58-F2BDF89C6F40Q28367245-35D0EFC2-BC83-4B9A-8B9C-8B724DFEB6AD
P2860
The catecholamine hypothesis of affective disorders: a review of supporting evidence
description
1965 nî lūn-bûn
@nan
1965 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1965 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1965年の論文
@ja
1965年論文
@yue
1965年論文
@zh-hant
1965年論文
@zh-hk
1965年論文
@zh-mo
1965年論文
@zh-tw
1965年论文
@wuu
name
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@ast
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@en
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@en-gb
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@nl
type
label
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@ast
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@en
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@en-gb
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@nl
prefLabel
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@ast
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@en
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@en-gb
The catecholamine hypothesis of affective disorders: a review of supporting evidence
@nl
P3181
P356
P1476
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
@en
P2093
JOSEPH J. SCHILDKRAUT
P304
P3181
P356
10.1176/AJP.122.5.509
P407
P577
1965-11-01T00:00:00Z